全球胃癌診斷市場:到 2028 年的預測——COVID-19 影響醫療保健提供者、症狀類型、液體、程序、產品、疾病名稱分析
市場調查報告書
商品編碼
1240689

全球胃癌診斷市場:到 2028 年的預測——COVID-19 影響醫療保健提供者、症狀類型、液體、程序、產品、疾病名稱分析

Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider, Symptom Type, Body Fluid, Procedure, Offering, and Disease Indication

出版日期: | 出版商: The Insight Partners | 英文 397 Pages | 訂單完成後即時交付

價格

胃癌診斷市場預計將從 2022 年的 13.0796 億美元增長到 2028 年的 19.1203 億美元,預計 2022 年至 2028 年的複合年增長率為 6.5%。

胃腸道腫瘤、淋巴瘤和腺癌患者數量龐大、老年人口增加、飲酒和吸煙增加是導致胃癌診斷程序市場規模擴大的一些因素。 然而,醫學實驗室專業人員的短缺阻礙了胃癌診斷程序市場的增長。

胃癌是一種形成胃壁的惡性癌症。 年齡、飲食和胃部疾病等風險因素可能導致胃癌的發展。 胃癌的症狀包括消化不良、胃灼熱、腹脹和胃部不適或疼痛。

許多進入胃癌診斷市場的市場參與者和研究機構正在開發先進的產品,以擴大他們的產品組合併增加他們的市場份額。 這些公司投入巨資研發先進產品。 下面介紹了與胃癌診斷平台相關的一些最新進展。

Ibex Medical Analytics 是人工智能癌症診斷領域的先驅,它開發了世界上第一個檢測癌症的人工智能 (AI) 平台。 它的 AI 算法可以分析活檢圖像、定位它們並對腫瘤進行分級。 這些結果有助於病理學家準確診斷胃癌。 2021 年 6 月,美國食品和藥物管理局 (FDA) 授予 Ibex 的 Galen 平台突破性設備稱號,加快了臨床審查和監管審批。 Galen Gastric 是一種集成的診斷和質量控制解決方案,支持病理學家檢測胃癌、異型增生、幽門螺桿菌和其他重要的臨床發現。

2019 年 11 月,全球首批實時內窺鏡 AI 開發商之一 AI Medical Services, Inc. 獲得美國 FDA 的批准,用於分析內窺鏡圖像以進行胃癌潛在診斷的 AI 程序。突破性設備指定 2022 年 2 月,Mayo Clinic 的研究人員使用人工智能和信息學發現了一個 32 基因特徵,它是胃癌患者的預後和預測生物標誌物。 這項研究發表在 Nature Communications 版上。 因此,這種基於 AI 的胃癌診斷的開創性有望在預測期內為胃癌診斷程序市場引入新趨勢。

COVID-19 大流行改變了每個國家/地區的經濟狀況和社會行為。 政府為遏制疾病傳播而採取的遏制措施改變了美國醫療保健服務的提供模式。 根據急診醫學部的數據,2020 年全國許多城市的急診科 (ED) 就診人數下降了約 40%。 此外,門診預約和選擇性護理已被推遲或由遠程醫療取代。

2021 年 11 月,Pfizer日本公司宣布了其在研 COVID-19 口服抗病毒候選藥物 PAXLOVID。 高危患者針對 COVID-19 的蛋白□抑制的中間階段 2/3 評估試驗 (EPIC-HR) 和非住院成人 COVID-19 重症高危患者的隨機雙盲試驗基於分析表明,據報導 PAXLOVID 疫苗可減少住院和死亡人數。 2021 年的前幾個月出現了與疫苗生產相關的供應限制。 然而,新工廠的建立和加速的技術轉變支持了美國和加拿大的加強疫苗生產和給藥方案。

此外,2021 年 3 月,Eurofins 的 Clinical Enterprise, Inc. 獲得了美國食品和藥物管理局 (FDA) 對 EmpowerDX COVID-19 Home 的 DTC(直接面向消費者)版本的緊急使用授權 (EUA)收集套件。得到。 Eurofins Home COVID-19 Nasal PCR 試劑盒是第一個商業化的 SARS-CoV-2 家庭檢測試劑盒。 同樣,在 2020 年 3 月,美國 FDA 宣布雅培是檢測新型冠狀病毒 (COVID-19) 最快的分子即時檢測,在大約 5 分鐘內提供陽性結果,在大約 13 分鐘內提供陰性結果。我們有頒發了緊急使用授權 (EUA)。 因此,越來越多的產品發布正在支持胃癌診斷市場。

基於醫療保健提供者的見解

根據醫療服務提供商,全球胃癌診斷程序市場細分為診斷實驗室、醫院、癌症研究機構、腫瘤診所等。 2022年,醫院板塊佔比最大。 未來幾年,癌症研究機構板塊預計將以最快的速度增長。

基於症狀類型的見解

根據症狀類型,胃癌診斷程序市場分為有症狀和無症狀。 到 2022 年,無症狀人群將佔據更大的市場份額。 此外,估計有症狀的部分在預測期內將以較大的複合年增長率增長。

基於體液的見解

胃癌診斷市場按體液細分為血液、尿液、唾液、洗胃液/胃液、組織等。 2022年,血液板塊將佔據最大份額。 此外,組織部分預計將在未來幾年內以最快的速度增長。

基於過程的洞察力

根據程序,胃癌診斷程序市場細分為內窺鏡程序、活檢和組織學、實驗室測試、體外診斷測試、成像測試、分子診斷、多重分子診斷和免疫測定等。 2022年影像檢測領域佔比最大。 內窺鏡部分預計將在未來幾年內以最快的速度增長。

在準備胃癌診斷市場報告時參考的主要一手和二手資料來源是世界衛生組織 (WHO)、美國人口普查局、美國國家醫學圖書館等。

內容

第一章介紹

  • 調查範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球胃癌診斷市場 - 按醫療保健提供商分類
    • 全球胃癌診斷程序市場 - 按症狀類型
    • 全球胃癌診斷程序市場 - 按體液分類
    • 全球胃癌診斷程序市場 - 按程序分類
    • 全球胃癌診斷設備市場 - 按產品分類
    • 全球胃癌診斷程序市場 - 按疾病適應症分類
    • 全球胃癌診斷市場 - 按地區劃分

第 2 章胃癌診斷市場-要點

第三章研究方法論

  • 報導
  • 二次調查
  • 關於初步調查

第 4 章胃癌診斷方法市場-市場狀況

  • 害蟲分析
    • 北美 PEST 分析
    • 歐洲 PEST 分析
    • 亞太地區 PEST 分析
    • 拉丁美洲 PEST 分析
    • 中東和非洲 PEST 分析
  • 專家意見

第 5 章胃癌診斷市場 - 主要市場動態

  • 市場驅動因素
    • 消化系統疾病患病率上升
    • 幽門螺桿菌感染激增
  • 市場製約因素
    • 醫學實驗室技術人員供不應求
  • 市場機會
    • 提高對胃癌的認識
  • 未來趨勢
    • 使用 AI 開發胃癌診斷平台
  • 影響分析

第 6 章胃癌診斷市場 - 全球分析

  • 胃癌診斷方法全球市場收入和預測/分析
  • 全球胃癌診斷程序市場,按地區 - 預測和分析
  • 主要參與者的市場定位
  • 全球胃癌診斷程序市場 - 各地區的市場潛力分析
  • 比較公司分析
  • 增長戰略分析
  • 主要參與者的表現
    • F. Hoffmann-La Roche
    • Thermo Fisher Scientific, Inc.

第 7 章全球胃癌診斷程序市場 - 收入和到 2028 年的預測 - 按醫療保健運營商

  • 診斷實驗室
  • 醫院
  • 癌症研究所
  • 腫瘤專科門診
  • 其他

第 8 章胃癌診斷程序的全球市場分析和到 2028 年的預測 - 按症狀類型

  • 按症狀
  • 無症狀

第 9 章全球胃癌診斷程序市場-收入和到 2028 年的預測-體腔液

  • 血液
  • 尿液
  • 唾液
  • 胃液/胃液
  • 紙巾
  • 其他

第 10 章全球胃癌診斷程序市場 - 收入和到 2028 年的預測 - 按程序

  • 內窺鏡手術
  • 活檢/組織檢查
  • 實驗室測試
  • 體外診斷檢查設備
  • 圖像檢查
  • 分子生物學診斷方法
  • 分子診斷和免疫測定的多重分析
  • 其他

第 11 章全球胃癌診斷程序市場-收入和到 2028 年的預測-按產品分類

  • 儀器
  • 試劑和耗材
  • 服務內容

第 12 章全球胃癌診斷程序分析 - 按適應症

  • 早期胃癌
  • 晚期胃癌

第 13 章胃癌診斷程序市場 - 收入和到 2028 年的預測 - 區域分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
Product Code: TIPRE00029842

The gastric cancer diagnostic procedure market is expected to grow from US$ 1307.96 million in 2022 to US$ 1912.03 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

The presence of a huge patient population with gastrointestinal tumors, lymphoma, and adenocarcinoma, the increase in the geriatric population, and the rise in alcohol consumption and smoking are among the factors contributing to the growing gastric cancer diagnostic procedure market size. However, the shortage of medical laboratory professionals hinders the growth of the gastric cancer diagnostic procedures market.

Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.

Many market players and research institutes operating in the gastric cancer diagnostics market are developing advanced products to expand their product portfolios and increase their market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to gastric cancer diagnostic platforms are mentioned below:

Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, developed the world's first artificial intelligence (AI) platform to detect cancer. Its AI algorithms analyze images of biopsies and can pinpoint their location and grade the tumor. These results help pathologists diagnose gastric cancer accurately. In June 2021, the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to Ibex's Galen platform, which will expedite the clinical review and regulatory approval of its platform. Galen Gastric is an integrated diagnostics and quality control solution that supports pathologists in the detection of gastric cancer, dysplasia, H. pylori, and other important clinical findings.

In November 2019, AI Medical Service Inc., one of the world's first real-time endoscopic AI developers, secured Breakthrough Device Designation by the US FDA for its AI programs that analyze endoscopy images for potential diagnosis of gastric cancer. In February 2022, Mayo Clinic researchers used AI and informatics to discover a 32-gene signature that is a prognostic and predictive biomarker for patients suffering from gastric cancer. The study was published in the edition of Nature Communications.Thus, such development of AI-based gastric cancer diagnostics are likely to introduce new trends in the gastric cancer diagnostic procedure market during the forecast period.

The COVID-19 pandemic altered economic conditions and social behaviors in countries. Containment measures enacted by governments to mitigate the spread of disease changed the pattern of healthcare service delivery in the US. According to the Department of Emergency Medicine, in many cities across the country, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.

In November 2021, Pfizer Inc. announced the investigational COVID-19 oral antiviral candidate, PAXLOVID. Based on an interim analysis of the Phase 2/3 Evaluation of Protease Inhibition for COVID-19 in high-risk patients (EPIC-HR) and a randomized, double-blind study of non-hospitalized adult patients with COVID-19, who were at a high risk of progressing to severe illness, it was observed that the PAXLOVID vaccine reportedly reduced hospitalization and death. There were supply constraints related to vaccine production in the initial months of 2021. However, setting up new plants and promoting technological shifts supported the production of booster doses in the US and Canada, along with their administration plans.

Furthermore, In March 2021, Eurofins' Clinical Enterprise, Inc. obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a direct-to-consumer (DTC) version of its EmpowerDX COVID-19 Home Collection Kit. The Eurofins at-home COVID-19 nasal PCR kit is one of the first over-the-counter SARS-CoV-2 at-home test kits. Similarly, in March 2020, the US FDA issued Emergency Use Authorization (EUA) to Abbott for its fastest available molecular point-of-care test to detect novel coronavirus (COVID-19), which delivers positive results in approximately 5 minutes and negative results in around 13 minutes. Thus, the rise in product launches is supporting the gastric cancer diagnostic procedure market.

Healthcare Providers-Based Insights

Based on healthcare providers, the global gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, others. In 2022, the hospitals segment held the largest share of the market. The cancer research institutes segment is expected to grow at the fastest rate during the coming years.

Symptom Type-Based Insights

Based on symptom type, the gastric cancer diagnostic procedure market is bifurcated into symptomatic and asymptomatic. In 2022, the asymptomatic segment held a larger share of the market. Moreover, the symptomatic segment is estimated to grow at significant CAGR during the forecast period.

Body Fluid-Based Insights

The gastric cancer diagnostic procedure market, by body fluid, is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. In 2022, the blood segment held the largest share of the market. Moreover, the tissue segment is expected to grow at the fastest rate during the coming years.

Procedures-Based Insights

The gastric cancer diagnostic procedure market, based on procedures, is segmented into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics and immunoassays, and others. In 2022, the imaging tests segment held the largest share of the market. The endoscopic segment is expected to grow at the fastest rate during the coming years.

A few of the major primary and secondary sources referred to while preparing the report on the gastric cancer diagnostic procedure market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the gastric cancer diagnostic procedure market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global gastric cancer diagnostic procedure market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Gastric cancer diagnostic procedure Market - by Healthcare Providers
    • 1.3.2 Global Gastric Cancer Diagnostic Procedure Market - By Symptom Types
    • 1.3.3 Global Gastric Cancer Diagnostic Procedure Market - By Body Fluid
    • 1.3.4 Global Gastric Cancer Diagnostic Procedure Market - By Procedures
    • 1.3.5 Global Gastric Cancer Diagnostic Procedure Market - By Offerings
    • 1.3.6 Global Gastric Cancer Diagnostic Procedure Market - By Disease Indication
    • 1.3.7 Global Gastric cancer diagnostic procedure Market - by Geography

2. Gastric Cancer Diagnostic Procedure Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Gastric cancer diagnostic procedure Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis
  • 4.3 Expert's Opinion

5. Gastric Cancer Diagnostic Procedure Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 5.1.2 Surging Cases of Helicobacter Pylori Infection
  • 5.2 Market Restraints
    • 5.2.1 Shortage of Medical Laboratory Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Rising Awareness of Gastric Cancer
  • 5.4 Future Trends
    • 5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform
  • 5.5 Impact Analysis

6. Gastric Cancer Diagnostic Procedure Market - Global Analysis

  • 6.1 Global Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis
  • 6.2 Global Gastric Cancer Diagnostic Procedure Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players
  • 6.4 Global Gastric Cancer Diagnostic Procedure Market - Market Potential Analysis, by Region
  • 6.5 Comparative Company Analysis
  • 6.6 Growth Strategy Analysis
  • 6.7 Performance of Key Players
    • 6.7.1 F. Hoffmann-La Roche Ltd
    • 6.7.2 Thermo Fisher Scientific Inc

7. Global Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 - by Healthcare Providers

  • 7.1 Overview
  • 7.2 Diagnostic Laboratories
    • 7.2.1 Overview
    • 7.2.2 Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • 7.3 Hospitals
    • 7.3.1 Overview
    • 7.3.2 Hospitals: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Cancer Research Institutes
    • 7.4.1 Overview
    • 7.4.2 Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Oncology Specialty Clinics
    • 7.5.1 Overview
    • 7.5.2 Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Gastric Cancer Diagnostic Procedure Market Analysis and Forecasts to 2028 - by Symptom Types

  • 8.1 Overview
  • 8.2 Symptomatic
    • 8.2.1 Overview
    • 8.2.2 Symptomatic: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.3 Asymptomatic
    • 8.3.1 Overview
    • 8.3.2 Asymptomatic: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)

9. Global Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 - by Body Fluid

  • 9.1 Overview
  • 9.2 Blood
    • 9.2.1 Overview
    • 9.2.2 Blood: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.3 Urine
    • 9.3.1 Overview
    • 9.3.2 Urine: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Saliva
    • 9.4.1 Overview
    • 9.4.2 Saliva: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Stomach Wash/Gastric Juice
    • 9.5.1 Overview
    • 9.5.2 Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Tissue
    • 9.6.1 Overview
    • 9.6.2 Tissue: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Other: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)

10. Global Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 - by Procedure

  • 10.1 Overview
  • 10.2 Endoscopic Procedure
    • 10.2.1 Overview
    • 10.2.2 Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Biopsy and Tissue Tests
    • 10.3.1 Overview
    • 10.3.2 Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Lab Tests
    • 10.4.1 Overview
    • 10.4.2 Lab Tests: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 In-Vitro Diagnostic Tests
    • 10.5.1 Overview
    • 10.5.2 In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.6 Imaging Tests
    • 10.6.1 Overview
    • 10.6.2 Imaging Tests: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.7 Molecular Diagnostics
    • 10.7.1 Overview
    • 10.7.2 Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.8 Multiplexing Molecular Diagnostics and Immunoassay
    • 10.8.1 Overview
    • 10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.9 Others
    • 10.9.1 Overview
    • 10.9.2 Others: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)

11. Global Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 - by Offerings

  • 11.1 Overview
  • 11.2 Instruments
    • 11.2.1 Overview
    • 11.2.2 Instruments: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.3 Reagents and Consumables
    • 11.3.1 Overview
    • 11.3.2 Reagents and Consumables: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Services
    • 11.4.1 Overview
    • 11.4.2 Services: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)

12. Global Gastric Cancer Diagnostic Procedure Analysis - by Disease Indication

  • 12.1 Overview
  • 12.2 Early Gastric Cancer
    • 12.2.1 Overview
    • 12.2.2 Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.3 Gastric Cancer Advanced Types
    • 12.3.1 Overview
    • 12.3.2 Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)

13. Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 13.1 North America: Gastric Cancer Diagnostic Procedure Market
    • 13.1.1 Overview
    • 13.1.2 North America: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
    • 13.1.3 North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
      • 13.1.3.1 North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
      • 13.1.3.2 North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
      • 13.1.3.3 North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
      • 13.1.3.4 North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
    • 13.1.4 North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
    • 13.1.5 North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
    • 13.1.6 North America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
      • 13.1.6.1 North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
      • 13.1.6.2 North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
      • 13.1.6.3 North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019-2028 (US$ Million)
      • 13.1.6.4 North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
      • 13.1.6.5 North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
    • 13.1.7 North America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
    • 13.1.8 North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
    • 13.1.9 North America: Gastric Cancer Diagnostic Procedure Market, by Country
      • 13.1.9.1 US: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.1.1 Overview
        • 13.1.9.1.2 United States: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.1.3 United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.1.9.1.3.1 United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.1.9.1.3.2 United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.1.9.1.3.3 United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.1.9.1.3.4 United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.1.9.1.4 United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.1.9.1.5 United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.1.9.1.6 United States: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.1.9.1.6.1 United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.1.9.1.6.2 United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.1.9.1.6.3 United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.1.9.1.6.4 United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.1.9.1.6.5 United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.1.9.1.7 United States: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.1.9.1.8 United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.1.9.2 Canada: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.2.1 Overview
        • 13.1.9.2.2 Canada: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.2.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.1.9.2.3.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.1.9.2.3.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.1.9.2.3.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.1.9.2.3.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.1.9.2.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.1.9.2.5 Canada: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.1.9.2.6 Canada: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.1.9.2.6.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.1.9.2.6.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.1.9.2.6.3 Canada: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.1.9.2.6.4 Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.1.9.2.6.5 Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.1.9.2.7 Canada Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.1.9.2.8 Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.1.9.3 Mexico: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.3.1 Overview
        • 13.1.9.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.1.9.3.3.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.1.9.3.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.1.9.3.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.1.9.3.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.1.9.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.1.9.3.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.1.9.3.6 Mexico: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.1.9.3.6.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.1.9.3.6.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.1.9.3.6.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.1.9.3.6.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.1.9.3.6.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.1.9.3.7 Mexico: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.1.9.3.8 Mexico: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
  • 13.2 Europe: Gastric Cancer Diagnostic Procedure Market
    • 13.2.1 Overview
    • 13.2.2 Europe: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.3 Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
      • 13.2.3.1 Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
      • 13.2.3.2 Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
      • 13.2.3.3 Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
      • 13.2.3.4 Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
    • 13.2.4 Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
    • 13.2.5 Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
    • 13.2.6 Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
      • 13.2.6.1 Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
      • 13.2.6.2 Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
      • 13.2.6.3 Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
      • 13.2.6.4 Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
      • 13.2.6.5 Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
    • 13.2.7 Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
    • 13.2.8 Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
    • 13.2.9 Europe: Gastric Cancer Diagnostic Procedure Market, by Country
      • 13.2.9.1 Germany: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.1 Overview
        • 13.2.9.1.2 Germany Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.3 Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.2.9.1.3.1 Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.2.9.1.3.2 Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.2.9.1.3.3 Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.2.9.1.3.4 Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.2.9.1.4 Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.2.9.1.5 Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.2.9.1.6 Germany Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.2.9.1.6.1 Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.2.9.1.6.2 Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.2.9.1.6.3 Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.2.9.1.6.4 Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.2.9.1.6.5 Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.2.9.1.7 Germany Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.2.9.1.8 Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.2.9.2 France: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.1 Overview
        • 13.2.9.2.2 France: Gastric cancer diagnostic procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.3 France: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019-2028 (US$ Million)
        • 13.2.9.2.3.1 France: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.2.9.2.3.2 France: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.2.9.2.3.3 France: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.2.9.2.3.4 France: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.2.9.2.4 France: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.2.9.2.5 France: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.2.9.2.6 France: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.2.9.2.6.1 France: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.2.9.2.6.2 France: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.2.9.2.6.3 France: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.2.9.2.6.4 France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.2.9.2.6.5 France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.2.9.2.7 France Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.2.9.2.8 France Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.2.9.3 UK: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.1 Overview
        • 13.2.9.3.2 UK: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.2.9.3.3.1 UK: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.2.9.3.3.2 UK: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.2.9.3.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.2.9.3.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.2.9.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.2.9.3.5 UK: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.2.9.3.6 UK: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.2.9.3.6.1 UK: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.2.9.3.6.2 UK: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.2.9.3.6.3 UK: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.2.9.3.6.4 UK: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.2.9.3.6.5 UK: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.2.9.3.7 UK: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.2.9.3.8 UK: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.2.9.4 Italy: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.1 Overview
        • 13.2.9.4.2 Italy: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.2.9.4.3.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.2.9.4.3.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.2.9.4.3.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.2.9.4.3.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.2.9.4.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.2.9.4.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.2.9.4.6 Italy: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.2.9.4.6.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.2.9.4.6.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.2.9.4.6.3 Italy: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.2.9.4.6.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.2.9.4.6.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.2.9.4.7 Italy: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.2.9.4.8 Italy: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.2.9.5 Spain: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.1 Overview
        • 13.2.9.5.2 Spain: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.2.9.5.3.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.2.9.5.3.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.2.9.5.3.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.2.9.5.3.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.2.9.5.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.2.9.5.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.2.9.5.6 Spain: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.2.9.5.6.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.2.9.5.6.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.2.9.5.6.3 Spain: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.2.9.5.6.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.2.9.5.6.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.2.9.5.7 Spain: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.2.9.5.8 Spain: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.2.9.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.1 Overview
        • 13.2.9.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.2.9.6.3.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.2.9.6.3.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.2.9.6.3.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.2.9.6.3.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.2.9.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.2.9.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.2.9.6.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.2.9.6.6.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.2.9.6.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.2.9.6.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.2.9.6.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.2.9.6.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.2.9.6.7 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.2.9.6.8 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
  • 13.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market
    • 13.3.1 Overview
    • 13.3.2 Asia Pacific: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
    • 13.3.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
      • 13.3.3.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
      • 13.3.3.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
      • 13.3.3.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
      • 13.3.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
    • 13.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
    • 13.3.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
    • 13.3.6 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
      • 13.3.6.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
      • 13.3.6.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
      • 13.3.6.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
      • 13.3.6.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
      • 13.3.6.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
    • 13.3.7 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
    • 13.3.8 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
    • 13.3.9 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country
      • 13.3.9.1 China: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.3.9.1.1 Overview
        • 13.3.9.1.2 China Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.3.9.1.3 China Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019-2028 (US$ Million)
        • 13.3.9.1.3.1 China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.3.9.1.3.2 China Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.3.9.1.3.3 China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.3.9.1.3.4 China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.3.9.1.4 China Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.3.9.1.5 China Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.3.9.1.6 China Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.3.9.1.6.1 China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.3.9.1.6.2 China Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
        • 13.3.9.1.6.3 China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019-2028 (US$ Million)
        • 13.3.9.1.6.4 China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019-2028 (US$ Million)
        • 13.3.9.1.6.5 China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019-2028 (US$ Million)
        • 13.3.9.1.7 China Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019-2028 (US$ Million)
        • 13.3.9.1.8 China Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019-2028 (US$ Million)
      • 13.3.9.2 Japan: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.3.9.2.1 Overview
        • 13.3.9.2.2 Japan: Gastric cancer diagnostic procedure Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.3.9.2.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019-2028 (US$ Million)
        • 13.3.9.2.3.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019-2028 (US$ Million)
        • 13.3.9.2.3.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019-2028 (US$ Million)
        • 13.3.9.2.3.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019-2028 (US$ Million)
        • 13.3.9.2.3.4 Japan: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019-2028 (US$ Million)
        • 13.3.9.2.4 Japan: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019-2028 (US$ Million)
        • 13.3.9.2.5 Japan: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019-2028 (US$ Million)
        • 13.3.9.2.6 Japan: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019-2028 (US$ Million)
        • 13.3.9.2.6.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019-2028 (US$ Million)
        • 13.3.9.2.6.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019-2028 (US$ Million)
      • 13.3.9.2.

List Of Tables

  • Table 1. North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. North America: Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. North America: Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. United States: Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. United States: Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Canada Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Canada Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Canada Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Canada Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Canada Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Canada Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Canada Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Canada Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Canada Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Canada Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Canada Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Canada Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Mexico Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Mexico Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Mexico Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Mexico Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Mexico Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Mexico Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Mexico Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Mexico Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Mexico Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Mexico Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Mexico Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Mexico Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Mexico Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Mexico Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Mexico Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Europe Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Europe Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. Germany Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 86. Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. Germany Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 91. France Gastric Cancer Diagnostic Procedure Market, by Healthcare providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. France Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 93. France Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 94. France Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. France Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 96. France Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 97. France Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 98. France Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 99. France Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. France Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 101. France Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 102. France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 103. France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. France Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 105. France Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 106. UK Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. UK Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 108. UK Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 109. UK Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 110. UK Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 111. UK Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 112. UK Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 113. UK Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 114. UK Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 115. UK Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 116. UK Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 117. UK Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 118. UK Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 119. UK Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 120. UK Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 121. Italy Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 122. Italy Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 123. Italy Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 124. Italy Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 125. Italy Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 126. Italy Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 127. Italy Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 128. Italy Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 129. Italy Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 130. Italy Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 131. Italy Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 132. Italy Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 133. Italy Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 134. Italy Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 135. Italy Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 136. Spain Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 137. Spain Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 138. Spain Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 139. Spain Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 140. Spain Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 141. Spain Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 142. Spain Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 143. Spain Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 144. Spain Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 145. Spain Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 146. Spain Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 147. Spain Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 148. Spain Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 149. Spain Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 150. Spain Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 151. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 152. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 153. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 154. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 155. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 156. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 157. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 158. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 159. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 160. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 161. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 162. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 163. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 164. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 165. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 166. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 167. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 168. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 169. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 170. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 171. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 172. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 173. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 174. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 175. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 176. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 177. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 178. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 179. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 180. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 181. China Gastric cancer diagnostic procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 182. China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 183. China Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 184. China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 185. China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 186. China Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 187. China Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 188. China Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 189. China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 190. China Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 191. China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 192. China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 193. China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 194. China Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 195. China Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 196. Japan Gastric Cancer Diagnostic Procedure Market, by Healthcare providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 197. Japan Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 198. Japan Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 199. Japan Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 200. Japan Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 201. Japan Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 202. Japan Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 203. Japan Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 204. Japan Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 205. Japan Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 206. Japan Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 207. Japan Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 208. Japan Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 209. Japan Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 210. Japan Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 211. India Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 212. India Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 213. India Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 214. India Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 215. India Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 216. India Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 217. India Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 218. India Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 219. India Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 220. India Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 221. India Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 222. India Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 223. India Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 224. India Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 225. India Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 226. South Korea Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 227. South Korea Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 228. South Korea Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 229. South Korea Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 230. South Korea Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 231. South Korea Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 232. South Korea Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 233. South Korea Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 234. South Korea Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 235. South Korea Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 236. South Korea Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 237. South Korea Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 238. South Korea Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 239. South Korea Gastric Cancer Diagnostic Procedure Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
  • Table 240. South Korea Gastric Cancer Diagnostic Procedure Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 241. Australia Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers - Revenue and Forecast to 2028 (US$ Million)
  • Table 242. Australia Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories - Revenue and Forecast to 2028 (US$ Million)
  • Table 243. Australia Gastric Cancer Diagnostic Procedure Market, by Hospitals - Revenue and Forecast to 2028 (US$ Million)
  • Table 244. Australia Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes - Revenue and Forecast to 2028 (US$ Million)
  • Table 245. Australia Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers - Revenue and Forecast to 2028 (US$ Million)
  • Table 246. Australia Gastric Cancer Diagnostic Procedure Market, by Symptom Types - Revenue and Forecast to 2028 (US$ Million)
  • Table 247. Australia Gastric Cancer Diagnostic Procedure Market, by Body Fluid - Revenue and Forecast to 2028 (US$ Million)
  • Table 248. Australia Gastric Cancer Diagnostic Procedure Market, by Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 249. Australia Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures - Revenue and Forecast to 2028 (US$ Million)
  • Table 250. Australia Gastric Cancer Diagnostic Procedure Market, by Lab Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 251. Australia Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 252. Australia Gastric Cancer Diagnostic Procedure Market, by Imaging Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 253. Australia Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 254. Australia Gastric Cancer Diagno

List Of Figures

  • Figure 1. Gastric Cancer Diagnostic Procedure Market Segmentation
  • Figure 2. Gastric Cancer Diagnostic Procedure Market, by Region
  • Figure 3. Global Gastric Cancer Diagnostic Procedure Market Overview
  • Figure 4. Asymptomatic Segment Held a Larger Share From Symptom Type Segment in Gastric Cancer Diagnostic Procedure Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Gastric Cancer Diagnostic Procedure Market, by Geography (US$ Million)
  • Figure 7. Global Gastric Cancer Diagnostic Procedure Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Gastric Cancer Diagnostic Procedure Market - Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. South & Central America: PEST Analysis
  • Figure 13. Middle East & Africa: PEST Analysis
  • Figure 14. Experts' Opinion
  • Figure 15. Gastric Cancer Diagnostic Procedure Market: Impact Analysis of Drivers and Restraints
  • Figure 16. Global Gastric Cancer Diagnostic Procedure Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 17. Global Gastric Cancer Diagnostic Procedure Market, by Geography - Forecast and Analysis (2020-2028)
  • Figure 18. Market Positioning of Key Players in Gastric Cancer Diagnostic Procedure Market
  • Figure 19. Global Gastric Cancer Diagnostic Procedure Market - Market Potential Analysis, by Region
  • Figure 20. Global Gastric Cancer Diagnostic Procedure Market - Comparative Company Analysis
  • Figure 21. Global Gastric Cancer Diagnostic Procedure Market - Growth Strategy Analysis
  • Figure 22. Global Gastric Cancer Diagnostic Procedure, by Healthcare Providers, 2021 & 2028 (%)
  • Figure 23. Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Hospitals: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Others: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Global Gastric Cancer Diagnostic Procedure, by Symptom Type, 2021 & 2028 (%)
  • Figure 29. Symptomatic: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Asymptomatic: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Global Gastric Cancer Diagnostic Procedure, by Body Fluid, 2021 & 2028 (%)
  • Figure 32. Blood: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Urine: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Saliva: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Tissue: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Other: Gastric Cancer Diagnostic Procedure Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Global Gastric Cancer Diagnostic Procedure, by Procedures, 2021 & 2028 (%)
  • Figure 39. Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Lab Tests: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Imaging Tests: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Others: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Global Gastric Cancer Diagnostic Procedure, by Offerings, 2021 & 2028 (%)
  • Figure 48. Instruments: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Reagents and Consumables: Global Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Services: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Global Gastric Cancer Diagnostic Procedure, by Disease Indication, 2021 & 2028 (%)
  • Figure 52. Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. North America: Gastric Cancer Diagnostic Procedure Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 55. North America Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. North America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%)
  • Figure 57. United States: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Canada: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Mexico: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Europe: Gastric Cancer Diagnostic Procedure Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 61. Europe Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Europe: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%)
  • Figure 63. Germany Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. France: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. UK: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Italy: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Spain: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Rest of Europe: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 70. Asia Pacific Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%)
  • Figure 72. China Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Japan: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. India: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 75. South Korea: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 76. Australia: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 77. Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 78. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 79. South & Central America: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 80. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%)
  • Figure 81. Brazil: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 82. Argentina: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 83. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 84. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 85. Middle East & Africa Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 86. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%)
  • Figure 87. Saudi Arabia: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 88. South Africa: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 89. UAE: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 90. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 91. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 92. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 93. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
  • Figure 94. Impact of COVID-19 Pandemic on South & Central American Country Markets
  • Figure 95. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 96. Growth Strategies Done by the Companies in the Market, (%)